# Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19

> **NCT04322396** · PHASE2 · TERMINATED · sponsor: **Chronic Obstructive Pulmonary Disease Trial Network, Denmark** · enrollment: 117 (actual)

## Conditions studied

- Virus Diseases
- Infection Viral
- Corona Virus Infection

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Hydroxychloroquine
- **DRUG:** Placebo oral tablet
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04322396
- **Lead sponsor:** Chronic Obstructive Pulmonary Disease Trial Network, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-06
- **Primary completion:** 2021-02-02
- **Final completion:** 2021-02-02
- **Target enrollment:** 117 (ACTUAL)
- **Why stopped:** Recommended by the DSMB
- **Last updated:** 2021-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04322396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04322396, "Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04322396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*